Surgery Partners Past Earnings Performance
Past criteria checks 0/6
Surgery Partners has been growing earnings at an average annual rate of 37.5%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 11.2% per year.
Key information
37.5%
Earnings growth rate
52.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 11.2% |
| Return on equity | 3.0% |
| Net Margin | -2.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Nov 11
Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues
Oct 24Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger
Oct 05Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward
Jul 25Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden
Jul 13Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement
Jun 21We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now
May 31Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion
Apr 24Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Mar 18Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Feb 27The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)
Dec 19Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)
Oct 26Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?
Sep 17Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?
Aug 26The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising
Jul 21Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit
Jun 15A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
May 26There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital
Apr 14Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet
Mar 24Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jan 24We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt
Sep 26The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence
Aug 15Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M
Aug 02Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders
Jul 02Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Jun 27Revenue & Expenses Breakdown
How Surgery Partners makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,985 | -61 | 124 | 0 |
| 30 Jun 24 | 2,889 | -34 | 131 | 0 |
| 31 Mar 24 | 2,795 | 1 | 122 | 0 |
| 31 Dec 23 | 2,743 | -12 | 121 | 0 |
| 30 Sep 23 | 2,715 | -34 | 129 | 0 |
| 30 Jun 23 | 2,662 | -54 | 110 | 0 |
| 31 Mar 23 | 2,609 | -92 | 105 | 0 |
| 31 Dec 22 | 2,539 | -55 | 102 | 0 |
| 30 Sep 22 | 2,442 | -31 | 101 | 0 |
| 30 Jun 22 | 2,381 | -29 | 108 | 0 |
| 31 Mar 22 | 2,309 | -38 | 107 | 0 |
| 31 Dec 21 | 2,225 | -81 | 104 | 0 |
| 30 Sep 21 | 2,163 | -86 | 101 | 0 |
| 30 Jun 21 | 2,100 | -135 | 100 | 0 |
| 31 Mar 21 | 1,932 | -150 | 101 | 0 |
| 31 Dec 20 | 1,860 | -156 | 97 | 0 |
| 30 Sep 20 | 1,829 | -179 | 97 | 0 |
| 30 Jun 20 | 1,785 | -132 | 92 | 0 |
| 31 Mar 20 | 1,856 | -119 | 90 | 0 |
| 31 Dec 19 | 1,831 | -110 | 89 | 0 |
| 30 Sep 19 | 1,805 | -238 | 87 | 0 |
| 30 Jun 19 | 1,786 | -243 | 87 | 0 |
| 31 Mar 19 | 1,777 | -241 | 90 | 0 |
| 31 Dec 18 | 1,772 | -238 | 94 | 0 |
| 30 Sep 18 | 1,732 | -122 | 84 | 0 |
| 30 Jun 18 | 1,597 | -125 | 89 | 0 |
| 31 Mar 18 | 1,443 | -102 | 79 | 0 |
| 31 Dec 17 | 1,312 | -79 | 69 | 0 |
| 30 Sep 17 | 1,159 | -22 | 71 | 0 |
| 30 Jun 17 | 1,135 | 7 | 60 | 0 |
| 31 Mar 17 | 1,139 | 14 | 56 | 0 |
| 31 Dec 16 | 1,121 | 9 | 55 | 0 |
| 30 Sep 16 | 1,079 | 9 | 60 | 0 |
| 30 Jun 16 | 1,039 | 9 | 58 | 0 |
| 31 Mar 16 | 981 | 1 | 56 | 0 |
| 31 Dec 15 | 936 | 1 | 56 | 0 |
| 30 Sep 15 | 855 | -70 | 46 | 0 |
| 30 Jun 15 | 696 | -73 | 42 | 0 |
| 31 Mar 15 | 544 | -69 | 36 | 0 |
| 31 Dec 14 | 394 | -66 | 31 | 0 |
| 31 Dec 13 | 279 | -9 | 26 | 0 |
Quality Earnings: SGRY is currently unprofitable.
Growing Profit Margin: SGRY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SGRY is unprofitable, but has reduced losses over the past 5 years at a rate of 37.5% per year.
Accelerating Growth: Unable to compare SGRY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SGRY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: SGRY has a negative Return on Equity (2.98%), as it is currently unprofitable.